Deep Track Capital »

Enanta Pharmaceuticals shares owned by Deep Track Capital

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $31M 2.0M 15.77
2022-03-31 $14M 199k 71.18

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Immunovant (IMVT)
Guardant Health (GH)
Structure Therapeutics Sponsored Ads (GPCR)
Tarsus Pharmaceuticals (TARS)
Dynavax Technologies Corp Com New (DVAX)
Cytokinetics Com New (CYTK)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Vaxcyte (PCVX)
Maze Therapeatics (MAZE)
Vera Therapeutics Cl A (VERA)
BioMarin Pharmaceutical (BMRN)
Ionis Pharmaceuticals (IONS)
Nurix Therapeutics (NRIX)

View all positions for Deep Track Capital

Top funds holding Enanta Pharmaceuticals

BlackRock
Farallon Capital Management
Krensavage Asset Management
Vanguard Group
Deep Track Capital
Henderson Group
Millennium Management
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Point72 Asset Management
Hillsdale Investment Management
Marshall Wace
Invesco

View all funds holding Enanta Pharmaceuticals